SCHEMBL24687218

SCHEMBL24687218

c1ccc(-c2ccc(-c3ncnc(-c4ccc(-c5ccc6ccccc6c5)cc4)n3)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ MEN1 O00255 2/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ KMT2A Q03164 2/20 0.53
▸ TP53 P04637 1/20 0.53
▸ CYP1A2 P05177 1/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ ESR1 P03372 3/20 0.50
▸ ESR2 Q92731 3/20 0.50
▸ CYP17A1 P05093 1/20 0.49
▸ CYP19A1 P11511 1/20 0.49
▸ CYP11B1 P15538 1/20 0.49
▸ CYP11B2 P19099 1/20 0.49
▸ HSD17B1 P14061 1/20 0.47
▸ HSD17B2 P37059 1/20 0.47
▸ CYP1A1 P04798 1/20 0.46
▸ CYP1B1 Q16678 1/20 0.46
▸ ALOX5 P09917 1/20 0.44
▸ ADORA2A P29274 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25841432 1.00 KDM4E (0.53) KDM4ESMN1; SMN2MEN1ALDH1A1KMT2A
SCHEMBL24356804 0.96 SMN1; SMN2 (0.53) KDM4ESMN1; SMN2MEN1ALDH1A1KMT2A
SCHEMBL26453123 0.96 SMN1; SMN2 (0.53) KDM4ESMN1; SMN2MEN1ALDH1A1KMT2A
SCHEMBL18215052 0.94 KDM4E (0.54) KDM4ESMN1; SMN2MEN1ALDH1A1KMT2A
SCHEMBL24357481 0.94 ESR1 (0.50) KDM4ESMN1; SMN2MEN1ALDH1A1KMT2A
SCHEMBL30417008 0.94 ESR1 (0.50) KDM4ESMN1; SMN2MEN1ALDH1A1KMT2A
SCHEMBL21862890 0.93 KDM4E (0.50) KDM4ESMN1; SMN2MEN1ALDH1A1KMT2A
SCHEMBL17451057 0.88 KDM4E (0.47) KDM4ESMN1; SMN2MEN1ALDH1A1KMT2A
SCHEMBL23633521 0.88 MEN1 (0.59) KDM4ESMN1; SMN2MEN1ALDH1A1KMT2A
SCHEMBL22186311 0.88 MEN1 (0.59) KDM4ESMN1; SMN2MEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11469378-B2 Electroluminescent compound and electroluminescent device including the same LG DISPLAY CO., LTD. (KR) 2022-10-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11469378-B2 Electroluminescent compound and electroluminescent device including the same LEF1, CLCN2, PIEZO1 KDM4E 1689/4885SMN1; SMN2 3571/4885MEN1 651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback